Robert J. Bitterman - 25 Nov 2022 Form 4 Insider Report for Phio Pharmaceuticals Corp. (PHIO)

Role
Interim Executive Chairman, Director
Signature
Caitlin Kontulis, attorney-in-fact
Issuer symbol
PHIO
Transactions as of
25 Nov 2022
Net transactions value
+$1,136
Form type
4
Filing time
29 Nov 2022, 15:30:15 UTC
Previous filing
16 Nov 2022
Next filing
06 Dec 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PHIO Common stock, $0.0001 par value Purchase $1,050 +2,500 +3.8% $0.4200 68,326 25 Nov 2022 Direct F1
transaction PHIO Common stock, $0.0001 par value Purchase $86 +215 +0.31% $0.4000 68,541 29 Nov 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Includes shares of common stock underlying unvested restricted stock units.